Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Spironolactone can reduce hair growth in women with hirsutism.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Analog 23 is a promising compound for prostate cancer treatment.

Purple corn extract may help reduce prostate enlargement and inflammation.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Shallot extract may help with hair growth and treating hair loss.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Future drugs targeting specific hair growth steps could improve treatments for hair growth issues.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

The link between anabolic agents and colorectal cancer risk is unclear.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.